Extracellular Vesicles Derived from Hypoxic Human Mesenchymal Stem Cells Attenuate GSK3β Expression via miRNA-26a in an Ischemia-Reperfusion Injury Model. by 이승현 & 정보영
736 www.eymj.org
INTRODUCTION
The main goals in patients with acute myocardial infarction 
are to minimize myocardial damage, enhance cardiac repair, 
and decrease myocardial remodeling. Current high-tech ther-
apy involves speedy reperfusion of the infarcted myocardium 
through revascularization of the occluded vessel. However, the 
advantage of reperfusion is compromised by the endothelial 
damage and inflammation that follow the reinstitution of the 
blood flow, leading to additional myocardial damage in a pro-
cess named “ischemia/reperfusion (IR) injury.”1-3 IR injury 
can be accompanied by lethal ventricular arrhythmias in ad-
dition to the myocardial injury. 
Mesenchymal stem cells (MSCs), and other cell types, re-
lease extracellular vesicles (EVs) that play a role in intercellu-
lar communication by transporting mRNA, microRNA, and 
proteins between cells. EVs are a class of membrane-bound 
organelles secreted by various cell types.4 The potential for EVs 
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Purpose: Bioactive molecules critical to intracellular signaling are contained in extracellular vesicles (EVs) and have cardiopro-
tective effects in ischemia/reperfusion (IR) injured hearts. This study investigated the mechanism of the cardioprotective effects 
of EVs derived from hypoxia-preconditioned human mesenchymal stem cells (MSCs).
Materials and Methods: EV solutions (0.4 μg/μL) derived from normoxia-preconditioned MSCs (EVNM) and hypoxia-precondi-
tioned MSCs (EVHM) were delivered in a rat IR injury model. Successful EV delivery was confirmed by the detection of PKH26 
staining in hearts from EV-treated rats.
Results: EVHM significantly reduced infarct size (24±2% vs. 8±1%, p<0.001), and diminished arrhythmias by recovering electrical 
conduction, INa current, and Cx43 expression. EVHM also reversed reductions in Wnt1 and β-catenin levels and increases in GSK3β 
induced after IR injury. miRNA-26a was significantly increased in EVHM, compared with EVNM, in real-time PCR. Finally, in in vitro 
experiments, hypoxia-induced increases in GSK3β expression were significantly reduced by the overexpression of miRNA-26a. 
Conclusion: EVHM reduced IR injury by suppressing GSK3β expression via miRNA-26a and increased Cx43 expression. These 
findings suggest that the beneficial effect of EVHM is related with Wnt signaling pathway.
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to be used as therapeutic agents, or as biomarkers of pathologi-
cal states, has generated enormous interest.5,6 EVs have been im-
plicated in the process of a remarkable antitumor effect in can-
cer by ameliorating tumor immune suppression, metastasis, 
and angiogenesis, along with having a primary role in tissue re-
generation.7-9 EVs have been proposed to stimulate favorable 
signaling pathways in cardiovascular disease: for example, po-
tentially mediating the proangiogenic actions of human stem 
cells.10 Studies have reported that the beneficial activity of the 
conditioned medium from MSCs is attributable to EVs.11,12 Im-
portantly, exposure to various stressors can change the com-
position of EVs to change the surrounding microenvironment 
through EV-mediated cell-to-cell communication.13 In normal 
cell physiology, EV secretion is a protective process to eliminate 
harmful components released during harmful conditions, such 
as IR injury.14 Under hypoxic conditions, genetically modified 
bone marrow-derived MSCs overexpressing Akt1 have been 
found to release paracrine factors that exert cytoprotective ef-
fects on cardiomyocytes exposed to hypoxia.15 Another study 
of the helpful byproduct effects of MSCs reported the release 
of cytokines from bone marrow stem cells boosting new ves-
sel formation, inhibiting cardiomyocyte apoptosis, and main-
taining myocardial contractility.16 Recently, it was reported 
that MSC-derived exosomes increase ATP levels, decrease ox-
idative stress, activate the PI3K/Akt pathway, and increase 
phosphorylated-GSK3β levels to enhance myocardial viability 
and to prevent adverse remodeling after myocardial IR injury.17
Because GSK3β is associated with the Wnt-Fizzled pathway, 
we hypothesized that MSC-derived exosomes would attenuate 
IR injury by effecting Wnt pathways. To prove this hypothesis, 
we investigated whether EVs derived from MSCs cultured in 
hypoxic media (EVHM) influence Wnt1, GSK3β, and β catenin. 
We also compared Wnt-related miRNA levels between EVHM 
and EVs derived from MSCs cultured in normoxic media (EVNM), 
and found significant increases in miRNA (miR) 26a in EVHM. 
Finally, we demonstrated that EVHM directly targets GSK3β us-
ing anti-miR-26a.
MATERIALS AND METHODS
This investigation conformed to the Guide for the Care and Use 
of Laboratory Animals published by the US National Institutes 
of Health, and was approved by the animal ethics committee 
of Yonsei University College of Medicine and Cardiovascular 
Research Institute (approval reference number 2016-0135). 
Study groups
To establish an IR injury model, all adult male Sprague-Dawley 
rats (230±10 g) were anesthetized by intramuscular injection 
of ketamine hydrochloride (80 mg/kg) and xylazine hydro-
chloride (4 mg/kg). The rats were intubated, and were ventilated 
with positive pressure (180 mL/min) using a ventilator (Harvard 
Apparatus model 683, Millis, MA, USA). The small incision 
was operated at the left lateral costal rib to expose the heart. 
The left anterior descending artery was ligated for 1 h with a 
6-0 silk suture (Ethicon, Somerville, NJ, USA), followed by re-
perfusion for 3 h. Immediately after the initiation of reperfusion, 
125 μL of an EV solution (0.4 μg/μL) in phosphate buffered sa-
line (PBS) (IR+EVNM or IR+EVHM group) or PBS alone (IR group) 
was systemically injected via the leg veins of the rats. We used 
sham-operated rats as controls. The animals were sacrificed 3 
hours after the EV injection.
To measure the myocardial infarcted size, hearts were sec-
tioned and incubated in 1% 2,3,5-triphenyltetrazolium chlo-
ride (TTC; Sigma-Aldrich, St Louis, MO, USA) for 30 min at 
37°C. Each heart specimen was fixed for 24 h in 10% para-
formaldehyde. Myocardium was identified as red, whereas 
infarcted areas appeared yellow. The region of normal and in-
farcted left ventricular myocardium was directly assessed by 
planimetry using dedicated software (ImageJ software, NIH 
software). 
Immunohistochemical staining 
For immunostaining of heart tissue, the anterior walls of the 
left ventricles were harvested after being fixed with 10% form-
aldehyde in PBS (pH 7.4), embedded with paraffin, and then 
sectioned at a thickness at 4 µm. Immunostaining was detect-
ed with the avidin-biotin complex (ABC) method. The prima-
ry antibodies used were rabbit anti-Cx43 polyclonal antibody 
(1:2000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) de-
tecting only Cx43. To inactive tissue endogenous peroxidase 
was then blocked by incubation with peroxidase block for 30 
min, and then, the tissue sections were incubated for enzymat-
ic retrieval, followed by 10% blocking serum. The slides were 
incubated overnight at room temperature, immunohistochem-
istry was colored using the polymer method (Vectastain ABC 
kits, PK-4000, Vector Laboratories, Burlingame, CA, USA), and 
later color development was performed with diaminobenzi-
dine (DAB) and contrast staining with hematoxylin.
Western blotting
Rat heart samples were homogenized and centrifuged at 15000×g 
for 15 min at 4°C, and protein concentration was determined 
using the Pierce BCA Protein Assay kit (Thermo Scientific Inc., 
Rockford, IL, USA). The protein samples were separated using 
SDS-polyacrylamide gel, and the separated proteins were trans-
ferred to a nitrocellulose membrane (Bio-Rad, Richmond, CA, 
USA). After blocking with 10% non-fat milk/TBS-T for 1 h, the 
membrane was incubated with indicated primary antibodies 
[anti-CD81, HSP70, CD63 (System Biosciences, Palo Alto, CA, 
USA), Annexin, Integrin (Abcam, Cambridge, MA, USA), Wnt1, 
GSK3β, p-GSK3β, β-catenin, p-β-catenin (Cell Signaling, Dan-
vers, MA, USA), Cx43 (Santa Cruz Biotechnology), and GAPDH 
(at a dilution of 1:1000, Cell Signaling) overnight at 4°C, and 
then incubated with horseradish peroxidase-conjugated sec-
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ondary antibodies for 1h at room temperature. Western blot sig-
nals were assayed using a reinforced chemiluminescence detec-
tion system (ECL, Amersham Pharmacia Biotech, Piscataway, 
NJ, USA).18 
Real-time polymerase chain reaction
A total of 500 ng RNA was extracted using TRIzol® Reagent (In-
vitrogen, Carlsbad, CA, USA) according to the manufacturer’s 
instructions. cDNA was synthesized using a RevertAidTM First 
Strand cDNA Synthesis Kit (Fermentas, Ontario, Canada). 
Quantitative RT-PCR (qRT-PCR) was performed using SYBR® 
Premix Ex TaqTM II (TaKaRa, Otsu, Japan) for quantification. 
Triplicates were tested for each sample. The expression of the 
target miRNA were normalized by U6 snRNA, respectively. Pu-
rity of PCR products was identified using a melting curve.
miR and anti-miRNA transfection
We used four intended miRNA target prediction algorithms: 
DIANA-microT3.1, MirTarget2, miRDB, and TargetScan5.1. 
Conserved miRNAs that are expected to target a given gene in at 
least three of the four algorithms were considered as candidates 
for further analysis (Supplementary Figs. 1 and 2, only online).
miR targeting GSK3β and miR-26a-specific anti-miRNA were 





























































Fig. 1. Isolation, characterization, and delivery of EVs. (A) Isolation of EV-rich fractions from human MSC media using a standard protocol of serial dif-
ferential centrifugation and ultracentrifugation steps. (B) Transmission electron microscopy image showing typical EVs. (C) Nanoparticle tracking 
analysis of EVs showing the number and size distributions of particles. (D) Western blot of HSP70, Annexin, integrin, and CD63. (E and F) PKH26-la-
beled IR+EVHM was detected in the H9C2 cells (E) and heart tissue after leg vein injection (F); white arrows, PKH26. EV, extracellular vesicle; MSC, 
mesenchymal stem cell; IR, ischemia/reperfusion; EVHM, hypoxia-preconditioned extracellular vesicles.
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(Invitrogen, Carlsbad, CA, USA) as per the manufacturer’s in-
structions. After transfection for the indicated time periods, 
cells were analyzed for proliferation, and formaldehyde-fixed 
cells were obtained for immunofluorescence analysis.19
Immunofluorescence staining
Cells from the control and experimental groups were grown on 
general cell culture dishes and a flexible energy harvester, re-
spectively. The cultured cells were fixed with 4% ice-cold form-
aldehyde (pH 7.2–7.3) for 1 h at room temperature, and then 
washed and permeated with 0.3% Triton X-100 for 30 min. Cells 
were washed and blocked with 5% bovine serum albumin (BSA) 
and 0.3% Triton X-100 in PBS for 30 min. Cells were washed 
and stained with GSK3β (Santa Cruz Biotechnology) and phos-
phor β-catenin (Santa Cruz Biotechnology) primary antibod-
ies using 1% BSA with 0.3% Triton X-100 in PBS overnight in a 
cold room at 4°C. Cells were washed and stained with Alexa 
Fluor 488 and Alexa 555 secondary antibodies using 1% BSA 
with 0.3% Triton X-100 in PBS for 3 h at room temperature. Cells 
were washed three times for 5 min, and then stained with 4’,6-di-
amidino-2-phenylindole (DAPI) during the final wash. Fluores-
cence images were recorded using a confocal microscope.
Statistical analysis
Data are presented as the mean±SEM. Patch clamp data were 
analyzed using pClamp software, version 10.4 (Axon Instru-
ments, Foster City, CA, USA) and Origin Pro, version 9.0 (Origin-
Lab Corp., Northampton, MA, USA). The parameters indicat-
ed under the different S1–S2 intervals, and multiple comparisons 
were determined by ANOVA analysis with Bonferroni post-
hoc analyses. A value of p<0.05 was considered statistically 
significant. Details of materials and experimental procedures 
are available in Supplementary Materials and Methods (only 
online).
RESULTS
Confirmation of EV characteristics and transfer to 
cardiomyoblasts
Fifteen milliliters of each human MSC culture was pelleted at 
300×g for 10 min to remove dead cells. Next, supernatants from 
both cell cultures were obtained by centrifugation at 750×g for 
5 min and then at 1500×g for 15 min to remove large debris and 
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  VT/VF    Non VT/VF
Fig. 2. Systemic injection of EVHM decreases IR injury and arrhythmias in a rat IR injury model. (A and B) Comparison of 2,3,5-triphenyltetrazolium chlo-
ride (TTC) staining and reduction in the infarct size by the EVs (n=6 per group). (C) Typical examples of an EKG in the IR (n=10) and IR+EV (n=8) groups. 
(D) Typical examples of VT and VF in the IR group (n=10). (E) Comparison of spontaneous VT or VF. All data are presented as the mean±SEM; *p<0.001. 
EV, extracellular vesicle; IR, ischemia/reperfusion; VT, ventricular tachycardia; VF, ventricular fibrillation; EVHM, hypoxia-preconditioned extracellular 
vesicles; EVNM, normoxia-preconditioned extracellular vesicles.
740
Extracellular Vesicles and Cardioprotection
https://doi.org/10.3349/ymj.2018.59.6.736
pelleted and washed 3 times (45 min at 14000×g, room tem-
perature) (Fig. 1A).
We confirmed the diameter of isolated EVs were <1000 nm 
using transmission electron microscopy (Fig. 1B) and 
nanoparticle tracking analysis (Fig. 1C). EVs were electropho-
resed and analyzed by Western blotting using anti CD81, 
Hsp70, Annexin, integrin, and CD63 antibodies (Fig. 1D). 
PKH26-labeled IR+EVHM was detected in H9C2 cells and heart 
tissue after leg vein injection (Fig. 1E and F).
EVHM attenuated IR injury and arrhythmias in 
IR-injured rats
Fig. 2A shows the extent of the infarct size assessed by histolo-
gy with TTC staining. Compared with the IR group (19±1%), the 
degree of infarct expansion was markedly decreased to a third 
in the IR+EVHM group (7±2%, p<0.001) (Fig. 2B). The typical ST-
segment elevation after IR injury was not observed in the IR+ 
EVHM group (Fig. 2C). Fig. 2D shows examples of ventricular 
tachycardia (VT) and ventricular fibrillation (VF) recorded by 
ambulatory Holter monitoring in the IR group. While sponta-
neous VT or VF was not observed in control rats, they were ob-
served in six (60%) rats in the IR group (p=0.003). However, the 
VT episodes were not observed after systemic EVHM treatment 
in the IR group (p<0.001) (Fig. 2E).
Fig. 3A and B show traces of action potentials (APs) and the 
typical maps of activation and AP duration (APD) at a pacing 
cycle length (CL) of 300 ms. In the IR group, the amplitude of 
APD of border (②) and infarcted zone (③) were noticeably 
improved, and activation was hindered. However, the ampli-
tude of APD in the IR-injured zone was significantly restored, 
and activation was spread wider inside the infarcted zone in 
the IR+EVHM group. The EVHM treatment reversed IR-induced 
APD shortening. Fig. 3C show representative examples of con-
duction velocity (CV) maps for all four groups, and the EVHM 
treatment generally recovered the IR-induced reduction of 
CV. The average CV was calculated from the vector maps at 
infarcted border zone or at corresponding sites. 
Conduction velocity was considerably slowed, and the slope 
of the CV restitution curve became steeper after IR. In the 
IR+EVHM group, the CV value and CV restitution slope were 
comparable to those of the control group. EVHM significantly re-
duced the induction rate of VT/VF in the IR injury group (67% 
vs. 0%, p<0.05) (Supplementary Fig. 3, only online).
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100 ms 1 cm
Fig. 3. Electrophysiologic effects of EVHM after IR injury. (A) Sample traces of Vm from the three groups (cycle length=300 ms). (B) Representative acti-
vation (left panels) and action potential duration maps (right panels) from the three groups. (C) Conduction velocity vector maps. EVHM, hypoxia-pre-
conditioned extracellular vesicles; EVNM, normoxia-preconditioned extracellular vesicles; IR, ischemia/reperfusion; LV, left ventricle, RV, right ventricle.
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Reversal of the sodium current (INa) reduced by 
hypoxic injury 
To determine whether EVHM directly alters the function of the 
cardiac sodium channel, INa was recorded in adult rat cardio-
myocytes of the control (n=5), IR (n=5), and IR+EVHM groups 
(n=5). As detailed in Table 1, compared with that recorded in 
the control cells (-73±2 pA/pF), the INa peak density was mark-
edly decreased in the IR cells (-31±2 pA/pF, p=0.001), but not 
after EVHM treatment (-80±7 pA/pF, p=0.002). The inactivation 
kinetics (τinact) were increased in the IR group (8±1 ms vs. 12±0.2 
ms, p=0.001), but preserved in the IR+ EVHM group (9±0.5 ms, 
p=0.001) (Fig. 4).
Since it is known that arrhythmia is particularly associated 
with gap junctions, we further examined the effects of EVHM on 
the levels of the gap junction protein Cx43. Whereas Cx43 (brown 
color, arrows) was sufficient at the cell-cell junctions in nor-
mal myocardium, Cx43 expression was decreased in IR myocar-
dium. Injection of EVHM resulted in the reorganization of Cx43 
at the cell-cell junction (Supplementary Fig. 4A, only online). 
According to Western blot assay of Cx43, IR-induced reduction 
of Cx43 (0.2-fold from normal) was recovered to 0.5-fold to 
normal level by EVHM treatment (Supplementary Fig. 4B, only 
online). This result shows that EVHM changed the gap junction 
that was interrupted by IR injury, and then leading to stable 
conduction. 
Effects of EV on the Wnt signaling pathway 
GSK-3β is associated with the Wnt-Fizzled pathway, and Wnt 
signaling is most well known to be a significant modulator of 
Cx43-dependent intercellular coupling in the heart.20 Thus, the 
level of Wnt signaling proteins were further assayed (Fig. 5A). 
After IR injury, compared with control, p-β-catenin/β-catenin 
increased by 2.6-fold (p<0.001), and p-GSK3β/GSK3β was de-
creased by 0.7-fold (p=0.036). Compared to IR, EVHM treat-
ment decreased p-β-catenin/β-catenin by 0.4-fold (p=0.004), 
and increased p-GSK3β/GSK3β by 1.4-fold (p=0.032) and 
Wnt1 by 1.3-fold (p<0.001) (Fig. 5B).
The putative target prediction of validated miRNAs by qRT-
PCR was performed using TargetScan (Version 6.2) and mirDB, 
providing an individual miRNA repression rate for target genes 
related with Wnt pathway. Combining this p-value and its abun-
dance value for each miRNA, the repression rates for the whole 
miRNA profile were calculated. Based on the results, the sig-
nificantly expressed five miRNAs were selected. To evaluate 
the change in miRNAs related with Wnt pathway after IR injury 
and EVHM treatment, we next performed qRT-PCR of miR-26, 
miR-148a, miR-31, miR-27a, miR-200a, and miR-34b in hearts 
from each study group. We found that miR-26a was significant-
ly deceased in the IR model and reversed after EVHM treatment 
(Fig. 5C). 
Cardioprotection effect of EVHM via miRNA26a 
It is widely known that upregulation of GSK3β and p-β-catenin 
is closely associated with IR injury. Fig. 6A shows confocal mi-
croscope images of H9C2 cells upon immunofluorescence 
staining for GSK3β and p-β-catenin. In hypoxic conditions, 
both GSK3β (3.1-fold) and p-β-catenin (3.8-fold) increased; 
however, EVHM and miR-26 effectively prevented increases in 
GSK3β (1.2-fold, p<0.001 vs. IR group) and p-β-catenin (1.1-fold, 
p<0.001 vs. IR group) in hypoxic conditions. After suppression 
Table 1. Effect of Extracellular Vesicles (EVs) on the Time Properties of the INa Current Recorded in Adult Rat Cardiomyocytes
Maximum INa density (pA/pF) Erev (mV) τact (ms) τinact (ms)
Control (n=5) -72.7±1.7 -35.8±3.7 0.7±0.1 8.1±0.8
IR (n=5)   -30.7±2.1* -32.5±1.6 0.5±0.2 12.3±0.2*
IR+EVHM (n=5) -80.3±6.7 -40.0±1.7 0.6±0.2 8.7±0.5
IR, ischemia/reperfusion; EVHM, hypoxia-preconditioned extracellular vesicles.
IR indicates hypoxia/reoxygenation.

















Fig. 4. EVHM recovers the sodium current (INa) after IR injury. Representative traces of whole-cell currents recorded from adult rat cardiomyocytes dur-
ing the control, IR, and IR+EVHM conditions (A). Current/voltage relationship of INa under the three conditions (B). The protocol is indicated in the inset, 
and the number of cells recorded was five in each group. EVHM, hypoxia-preconditioned extracellular vesicles; IR, ischemia/reperfusion.
A B
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of miR-26a using anti-miR-26a, the effect of EVHM was elimi-
nated; EVHM showed no effect on GSK3β and p-β-catenin (Fig. 
6B). The effects of miR-26a and anti-miR-26a on different con-
ditions are presented in Supplementary Fig. 5 (only online). 
DISCUSSION
The main findings of this study were that EVs derived from hy-
poxia-preconditioned MSCs attenuated IR injury by suppress-
ing GSK3β expression. Moreover, they increased electrical con-
duction and Cx43 expression by increasing Wnt1. Finally, miR-
26a was increased in EVs after hypoxic stress, and was related 
with decreases in GSK3β and p-β-catenin. These findings high-
light a potential new beneficial tool in IR injury.
Systemic injection of EVs protects the heart against IR 
injury
In this study, the degree of infarct expansion was markedly de-
creased by the systemic injection of EVs originating from hy-
poxic human MSCs. EVHM effectively attenuated increases in 
GSK3β, which is important in the process of IR injury. During 
ischemic preconditioning (IPC), GSK3β is phosphorylated and 
inhibited in a Wortmannin-sensitive manner.21 GSK-3β is in-
activated by phosphorylation. Akt, PKC, and PKA phosphorylate 
and inactivate GSK3β. FrzA, a secreted antagonist of the Wnt/
Frizzled pathway, decreases the phosphorylation of GSK3β, 
independent of Akt activity. Overexpression of FrzA blocks the 
IPC-mediated increase in phosphorylation of GSK3β and blocks 
the protection afforded by IPC.22 Phosphorylation and inacti-
vation of GSK3β are antiapoptotic. Tong, et al.23 showed that 
preconditioning results in increased phosphorylation of GSK3β, 
which is blocked by inhibitors of PI3K. In this study, EVHM re-
duced the sizes of infarct areas. We also confirmed that EVHM 
was well delivered to the infarct border zone. Therefore, EV func-
tions as a miRNA source to the cell of the infarct border zone.
EVHM improves electrical conduction
Cells in the surviving peri-infarct zone have prepotentials and 
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Fig. 5. EVs decrease and increase Wnt signaling proteins after IR injury and elevation of miRNA-26a in EVHM and the reversal of miRNA-26a by EVHM 
after IR injury. (A and B) Expression level of Wnt signaling proteins (e.g., Wnt1, GSK3β, p-GSK3β, β-catenin, and p-β-catenin) (n=6 per group). All data 
are presented as the mean±SEM; *p<0.05, **p<0.001. (C) Reversal of miRNA-26a after IR injury by EVHM (n=6 per group). Data are presented as the 
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discontinuous propagation due to abnormal cell-to-cell cou-
pling.24 Surviving border-zone tissue exhibits a decreased phase 
amplitude and upstroke velocity (dV/dtmax), reminiscent of a 
reduced INa.25 Isolated border zone cardiomyocytes also have 
a reduced dV/dtmax26 and marked irregularities in the INa, in-
cluding a diminished current density, increased inactivation, 
and slowed reactivation.27 Marked alterations in the gap junc-
tion organization and Cx43 distribution happen within improved 
myocardial infarctions.28 Thus, coupling irregularities due to 
Cx43 changes are central to ventricular arrhythmogenesis af-
ter infarction. This study showed that EVs improve Na+ current 
and Cx43 expression, which were decreased after IR injury. 
GSK3β is associated with the Wnt-Fizzled pathway, and Wnt 
signaling is best known to be a significant modulator of Cx43-
dependent intercellular coupling in the heart.20 Consistently, Wnt 
1 was significantly increased with EVHM in the IR injury model.
EVHM had a cardioprotective effect after IR injury via 
miRNA-26a 
EVs can directly interact with the ligands present on the sur-
face of target cells and activate cascade signaling. In addition, 
EVs can transfer proteins, mRNA, microRNA, and bioactive 
lipids by interacting with target cells by either fusion or inter-
nalization.29,30 Numerous miRNAs have been found to regu-
late regeneration and cardiac repair,31 and these microparticles 
have also been identified as immature mRNA when secreted 
from MSCs.32 The IR injury protective effect of EVs might be 
mediated by heat-shock proteins or a specific microRNA. It is 
noteworthy that heat shock protein 20, compared with other 
small heat-shock proteins, is mostly upregulated in animal 
hearts during ischemic conditions.33 Increased miRNA-494 lev-
els protect hearts against IR injury.34
Icli, et al.35 reported that miR-26a acts as a previously unrec-
ognized pivotal regulator of pathological and physiological an-
giogenesis by targeting a SMAD1-Id1-p21WAF/CIP1/p27 signal-
ing axis to promote an antiangiogenic program in ECs. Furthermore, 
neutralization of miR-26a was found to rapidly induce angio-
genesis, to reduce acute myocardial infarction (MI) size, and to 
improve heart function in mice. However, an acute IR model 
demonstrated an essential role for miR-26a in inhibiting high 
mobility group box-1 (HMGB1) expression and attenuating car-
diac IR injury. miR-26a overexpression results in reduced car-
diac IR injury and suppressed HMGB1 expression. Therefore, 
the discrepancy of the effect of miR-26 might be related with 
the stage of MI or model of MI.
GSK-3β is a key integration point in IPC, with GSK-3β phos-
phorylation/inhibition raising the threshold for oxidative stress-
induced mitochondrial permeability transition, and thereby pro-
tecting the heart.36 Many other studies have reported that the 
inhibition of GSK-3β mimics the effect of IPC and reduces in-
farct size in rats.21,37 In contrast, diabetic rat hearts show increased 
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Fig. 6. Confocal microscope image of H9C2 cells showing GSK3β and p-β-catenin staining in various conditions. (A) Hypoxia-preconditioned extracel-
lular vesicles (EVHM), compared with EVNM (normoxic), significantly prevented ischemia/reperfusion injury-induced increases in GSK3β and decreases 
in p-β-catenin. These effects were abrogated by anti-miRNA-26a. (B) Quantitative analysis of fluorescence signals in H9C2 cells stained for GSK3β 
and p-β-catenin.
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study, GSK-3β phosphorylation/inhibition of IR+EVHM model 
could explain the reduced infarct size of EVHM. Consistent with 
our report, Suh, et al.39 reported that up-regulation of miR-26a 
repress GSK-3β protein expression.
This study showed that increased miR-26a levels in EVHM 
protected hearts after IR injury. We also demonstrated that EVHM 
directly targets GSK3β using anti-miR-26a. The involvement 
of miR-26a in the suppression of GSK3β after IR injury was 
supported by the experiment showing that suppression of GSK3β 
by EVHM is eliminated by the transfection of anti-miR-26a. 
miR-26a was significantly deceased in the IR model and re-
versed after EVHM treatment. However, the delivery of miR-26 
by EVHM was not evaluated in this study. In H9C2 cells, EVNM 
also had a protective effect without statistical significance. In-
hibition with anti-miR-26a decreased effect of Hy+EVHM to the 
same level as Hy+EVNM. Therefore, the protective effect of EVNM 
might be miR-26a-independent. Moreover, the transfection of 
miR-26a successfully suppressed GSK3β in H9C2 cells after hy-
poxic stress. 
There are some limitations to our research. The proteins of 
the EVs were not assayed in this study. Kim, et al.40 profiled the 
MSC-EV proteome to investigate their therapeutic effects, and 
identified 730 EV proteins. A functional enrichment analysis 
showed that cellular processes represented by the MSC-EV 
proteins include cell proliferation, adhesion, migration, and 
morphogenesis. Therefore, the antiarrhythmic effects are re-
lated to the combined effects of several EV proteins. This study 
could not demonstrate whether miR-26a targets GSK3β di-
rectly. Dual luciferase assay should be carried out for the eval-
uation of miRNA binding on 3’UTR of GSK3β. Future studies 
are needed to reveal the detailed mechanism. 
In summary, our study demonstrates that EVHM reduced IR 
injury by suppressing GSK3β expression and increased Cx43 
expression suggesting that the beneficial effect of EVHM is re-
lated with Wnt signaling pathway. These effects might be cor-
related with miR-26a. These findings highlight a potential new 
beneficial tool in IR injury. Further study is need to reveal wheth-
er EV-derived miR-26 actually affects the function of the gap 
junction (or at least the amount of Cx43).
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